Astral Ltd Q1 FY27 Earnings Analysis

- Bathware category expected to grow at 25-30% CAGR due to low base and brand marketing push (Page 30). - Plumbing volume growth targeted at 10-15% for FY27, with accelerated growth and margin expansion post backward integration (Page 24). - Adhesive segment expected to grow at 15-20% in India, with UK at 10% (Page 24). - Paints category aimed for 25-30% growth in FY27, transitioning to positive EBITA (Page 16). - Overall piping industry volume growth anticipated around 8% in FY27, with value growth higher due to polymer price inflation (Page 12). - Export volumes doubled YoY with presence in 40 countries, export contribution expected to remain lower compared to domestic businesses (Pages 18, 15). - Capacity expansions planned with efficient utilization, supporting volume growth and market share gains (Pages 19, 28).

- Confident of becoming a positive EBITA company next year with good returns (Page 31). - Expecting pipe division EBITA margin of 16-18% in FY27, with conservative guidance due to volatile polymer prices (Pages 28-29). - Targeting 20-25% revenue growth for pipe division and 15-20% volume/revenue growth in adhesive category (Pages 28, 24). - Bathware expected to grow at 25-30% CAGR for the foreseeable future due to low base and increasing marketing efforts (Page 30). - CPVC backward integration expected to boost growth and margin expansion by ~200 basis points (Page 24). - Paints business anticipating 25%+ growth with improving operations and market acceptance (Page 11). - Overall, targeting 15-20% growth for adhesives and paints combined in FY27 (Page 16). - Industry volume growth expected around 8% in FY27, with value growth ~10% due to polymer price inflation (Page 12). - Management prioritizing volume growth, market share, and sustainable margin improvements amidst volatile environment (Pages 28-31).

- FY27 Capex target around ₹300 crores; FY26 spent ~₹360 crores. - Recent large capex done, with capacity expansions; machine installation ongoing, especially in CPVC backward integration plant (40,000 MT capacity). - Next CPVC expansion (to 1 lakh MT) requires additional equipment but significantly less investment as land, utilities, approvals are ready. Expected within 9 months post current phase. - Investment focus on decentralization for market share gain despite already available capacity. - Some capex allocated for R&D and product innovation, e.g., PEX aluminium PEX machines and polypropylene drainage pipe machinery—high cost but currently lower tonnage production. - Cash retained for potential opportunistic M&A or value-accretive investments within existing four portfolios (pipes, adhesives, paints, bathware). - Cost of new plants and land has roughly doubled compared to 4 years prior due to inflation; higher entry barriers for new competitors.

- No explicit mention of any current or planned fundraising through debt or equity was found. - Mr. Sandeep Engineer noted the company is keeping cash on the books due to global uncertainties and potential opportunities such as polymer cycles being favorable or potential M&A. - The company is not looking to surprise with new segments outside their current four portfolios. - Cash reserves are being maintained for strategic flexibility rather than immediate capital raising. - No statements indicate any imminent debt or equity issuance plans.

- On Page 24, it is mentioned that Astral cracked a ₹4 crore order against Coler in Bangalore, indicating growing market acceptance and active order inflow. - No explicit detailed numbers on the total current or expected order book or pending orders are provided in the transcript. - However, overall sentiments convey positive growth and confidence in order intake due to expansion in product lines such as bathware and CPVC capacity expansion. - The company is bullish about volume growth, market share gains, and accelerated production capacity which imply a healthy and growing order pipeline. - Backward integration in CPVC and expansion in bathware and adhesive businesses also suggest an increased order intake outlook for FY27 and beyond.